日本語English简体中文 繁體中文

300142 Walvax Biotechnology Co., Ltd.沃森生物Shenzhen Stock Exchange

13 posts

Walvax Biotechnology Co., Ltd. (300142) at a glance

Code
300142
Company
Walvax Biotechnology Co., Ltd.
Local name
沃森生物
Market
Shenzhen Stock Exchange
Share price
CN¥11.31 -0.14 (-1.22%) Nov 9 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Walvax Biotechnology Co., Ltd. (300142) Stock Price History

Walvax Biotechnology Co., Ltd. closed at CN¥11.31 on Nov 9, 2026, −23.3% over 1 month, −7.9% over 1 year.

2026-10-15 新薬・製品の承認 关于冻干带状疱疹病毒mRNA疫苗启动I期临床试验的公告2026-10-30 四半期報告 2026年三季度报告 / 取締役会決議 第六届董事会第十次会议决议公告 / 資産の減損 关于2026年第三季度计提资产减值准备及核销资产的公告CN¥14.75CN¥10.89Oct 9Nov 9
Price5-day MA25-day MASSE CompositeDisclosures
1-Month HighCN¥14.75Oct 9
1-Month LowCN¥10.89Oct 30
1-Week Change+2.2%vs Nov 2
1-Month Change−23.3%vs Oct 9

If you had invested CN¥10,000 1 month ago, it would be worth CN¥7,668 today (−23.3%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −4.3%, while this stock moved −23.3%.

Last 10 Trading Days

DateCloseChange% Change
Nov 9 (Mon)CN¥11.31−0.14−1.22%
Nov 6 (Fri)CN¥11.45−0.24−2.05%
Nov 5 (Thu)CN¥11.69+0.25+2.19%
Nov 4 (Wed)CN¥11.44+0.31+2.79%
Nov 3 (Tue)CN¥11.13+0.06+0.54%
Nov 2 (Mon)CN¥11.07+0.18+1.65%
Oct 30 (Fri)CN¥10.89−0.62−5.39%
Oct 29 (Thu)CN¥11.51−0.66−5.42%
Oct 28 (Wed)CN¥12.17+0.11+0.91%
Oct 27 (Tue)CN¥12.06−0.50−3.98%
2026-09-24 第三者割当増資 北京市竞天公诚律师事务所关于云南沃森生物技术股份有限公司2026年度… / 第三者割当増資 中信证券股份有限公司关于公司2026年度向特定对象发行股票之上市保荐… / 第三者割当増資 中信证券股份有限公司关于公司2026年度向特定对象发行股票之发行保荐… / 第三者割当増資 大信会计师事务所(特殊普通合伙)关于公司申请向特定对象发行股票的… / 第三者割当増資 关于云南沃森生物技术股份有限公司申请向特定对象发行股票的审核问询… / 監査報告 最近一年的财务报告及其审计报告以及最近一期的财务报告 / 第三者割当増資 北京市竞天公诚律师事务所关于云南沃森生物技术股份有限公司2026年度… / 第三者割当増資 2026年度向特定对象发行股票募集说明书(申报稿) / 第三者割当増資 关于向特定对象发行股票的审核问询函回复及募集说明书等申请文件更新…2026-10-15 新薬・製品の承認 关于冻干带状疱疹病毒mRNA疫苗启动I期临床试验的公告2026-10-30 四半期報告 2026年三季度报告 / 取締役会決議 第六届董事会第十次会议决议公告 / 資産の減損 关于2026年第三季度计提资产减值准备及核销资产的公告CN¥16.10CN¥10.89Aug 10Nov 9
Price5-day MA25-day MASSE CompositeDisclosures
3-Month HighCN¥16.10Aug 21
3-Month LowCN¥10.89Oct 30
1-Month Change−23.3%vs Oct 9
3-Month Change−13.9%vs Aug 7

If you had invested CN¥10,000 3 months ago, it would be worth CN¥8,614 today (−13.9%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −8.0%, while this stock moved −13.9%.

Last 10 Trading Days

DateCloseChange% Change
Nov 9 (Mon)CN¥11.31−0.14−1.22%
Nov 6 (Fri)CN¥11.45−0.24−2.05%
Nov 5 (Thu)CN¥11.69+0.25+2.19%
Nov 4 (Wed)CN¥11.44+0.31+2.79%
Nov 3 (Tue)CN¥11.13+0.06+0.54%
Nov 2 (Mon)CN¥11.07+0.18+1.65%
Oct 30 (Fri)CN¥10.89−0.62−5.39%
Oct 29 (Thu)CN¥11.51−0.66−5.42%
Oct 28 (Wed)CN¥12.17+0.11+0.91%
Oct 27 (Tue)CN¥12.06−0.50−3.98%
2026-09-24 第三者割当増資 北京市竞天公诚律师事务所关于云南沃森生物技术股份有限公司2026年度… / 第三者割当増資 中信证券股份有限公司关于公司2026年度向特定对象发行股票之上市保荐… / 第三者割当増資 中信证券股份有限公司关于公司2026年度向特定对象发行股票之发行保荐… / 第三者割当増資 大信会计师事务所(特殊普通合伙)关于公司申请向特定对象发行股票的… / 第三者割当増資 关于云南沃森生物技术股份有限公司申请向特定对象发行股票的审核问询… / 監査報告 最近一年的财务报告及其审计报告以及最近一期的财务报告 / 第三者割当増資 北京市竞天公诚律师事务所关于云南沃森生物技术股份有限公司2026年度… / 第三者割当増資 2026年度向特定对象发行股票募集说明书(申报稿) / 第三者割当増資 关于向特定对象发行股票的审核问询函回复及募集说明书等申请文件更新…2026-10-15 新薬・製品の承認 关于冻干带状疱疹病毒mRNA疫苗启动I期临床试验的公告2026-10-30 四半期報告 2026年三季度报告 / 取締役会決議 第六届董事会第十次会议决议公告 / 資産の減損 关于2026年第三季度计提资产减值准备及核销资产的公告CN¥16.10CN¥10.89May 11Nov 9
Price25-day MA75-day MASSE CompositeDisclosures
6-Month HighCN¥16.10Aug 21
6-Month LowCN¥10.89Oct 30
3-Month Change−13.9%vs Aug 7
6-Month Change−15.3%vs May 8

If you had invested CN¥10,000 6 months ago, it would be worth CN¥7,069 today (−29.3%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −13.6%, while this stock moved −29.3%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥11.31+3.9%
Oct 2026CN¥10.89−23.5%
Sep 2026CN¥14.23+4.7%
Aug 2026CN¥13.59+10.3%
Jul 2026CN¥12.32−5.2%
Jun 2026CN¥12.99+0.9%
May 2026CN¥12.87−1.0%
2026-09-24 第三者割当増資 北京市竞天公诚律师事务所关于云南沃森生物技术股份有限公司2026年度… / 第三者割当増資 中信证券股份有限公司关于公司2026年度向特定对象发行股票之上市保荐… / 第三者割当増資 中信证券股份有限公司关于公司2026年度向特定对象发行股票之发行保荐… / 第三者割当増資 大信会计师事务所(特殊普通合伙)关于公司申请向特定对象发行股票的… / 第三者割当増資 关于云南沃森生物技术股份有限公司申请向特定对象发行股票的审核问询… / 監査報告 最近一年的财务报告及其审计报告以及最近一期的财务报告 / 第三者割当増資 北京市竞天公诚律师事务所关于云南沃森生物技术股份有限公司2026年度… / 第三者割当増資 2026年度向特定对象发行股票募集说明书(申报稿) / 第三者割当増資 关于向特定对象发行股票的审核问询函回复及募集说明书等申请文件更新…2026-10-15 新薬・製品の承認 关于冻干带状疱疹病毒mRNA疫苗启动I期临床试验的公告2026-10-30 四半期報告 2026年三季度报告 / 取締役会決議 第六届董事会第十次会议决议公告 / 資産の減損 关于2026年第三季度计提资产减值准备及核销资产的公告CN¥16.10CN¥10.89Nov 10Nov 9
Price25-day MA75-day MASSE CompositeDisclosures
52-Week HighCN¥16.10Aug 21
52-Week LowCN¥10.89Oct 30
Year to Date+3.7%vs Dec 31
From 52-Week High−29.8%Aug 21

If you had invested CN¥10,000 1 year ago, it would be worth CN¥9,055 today (−9.4%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −9.2%, while this stock moved −9.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥11.31+3.9%
Oct 2026CN¥10.89−23.5%
Sep 2026CN¥14.23+4.7%
Aug 2026CN¥13.59+10.3%
Jul 2026CN¥12.32−5.2%
Jun 2026CN¥12.99+0.9%
May 2026CN¥12.87−1.0%
Apr 2026CN¥13.00+4.9%
Mar 2026CN¥12.39+0.2%
Feb 2026CN¥12.36−2.1%
Jan 2026CN¥12.63+15.8%
Dec 2025CN¥10.91−10.3%
Nov 2025CN¥12.16−0.6%
CN¥24.78CN¥9.96Nov 13, 2023Nov 9, 2026
Price13-week MA26-week MASSE Composite
3-Year HighCN¥24.78Nov 27, 2023
3-Year LowCN¥9.96Sep 16, 2024
Annualized Return−22.4%
Max Drawdown−59.8%

If you had invested CN¥10,000 3 years ago, it would be worth CN¥4,689 today (−53.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +19.5%, while this stock moved −53.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥11.31+3.7%
2025CN¥10.91―
CN¥67.60CN¥9.96Nov 15, 2021Nov 9, 2026
Price13-week MA26-week MASSE Composite
5-Year HighCN¥67.60Nov 22, 2021
5-Year LowCN¥9.96Sep 16, 2024
Annualized Return−29.0%
Max Drawdown−85.3%

If you had invested CN¥10,000 5 years ago, it would be worth CN¥1,813 today (−81.9%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +2.5%, while this stock moved −81.9%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥11.31+3.7%
2025CN¥10.91―
CN¥85.99CN¥4.12Dec 1, 2010Nov 9, 2026
Price1-year MA2-year MASSE Composite
All-Time HighCN¥85.99Jul 2021
All-Time LowCN¥4.12Jan 2012
Total Change+19.2%vs Dec 2010
Annualized Return+1.1%

If you had invested CN¥10,000 in Dec 2010, it would be worth CN¥11,922 today (+19.2%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +30.0%, while this stock moved +19.2%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥11.31+3.7%
2025CN¥10.91−9.7%
2024CN¥12.08−48.6%
2023CN¥23.51−41.5%
2022CN¥40.19−28.5%
2021CN¥56.20+45.7%
2020CN¥38.56+18.9%
2019CN¥32.44+69.8%
2018CN¥19.10+4.7%
2017CN¥18.25+67.4%
2016CN¥10.90−17.3%
2015CN¥13.18+95.9%
2014CN¥6.73+34.6%
2013CN¥5.00+4.4%
2012CN¥4.79−1.7%
2011CN¥4.87−48.6%
2010CN¥9.49―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Dec 2010). Please check the latest prices before trading.

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.13 Disclosure 2026/10/30 09:00
資産の減損
关于2026年第三季度计提资产减值准备及核销资产的公告
Delete
No.12 Disclosure 2026/10/30 09:00
取締役会決議
第六届董事会第十次会议决议公告
Delete
No.11 Disclosure 2026/10/30 09:00
四半期報告
2026年三季度报告
Delete
No.10 Disclosure 2026/10/15 09:00
新薬・製品の承認
关于冻干带状疱疹病毒mRNA疫苗启动I期临床试验的公告
Delete
No.9 Disclosure 2026/09/24 09:00
第三者割当増資
关于向特定对象发行股票的审核问询函回复及募集说明书等申请文件更新的提示性公告
Delete
No.8 Disclosure 2026/09/24 09:00
第三者割当増資
2026年度向特定对象发行股票募集说明书(申报稿)
Delete
No.7 Disclosure 2026/09/24 09:00
第三者割当増資
北京市竞天公诚律师事务所关于云南沃森生物技术股份有限公司2026年度向特定对象发行股票的补充法律意见书(一)
Delete
No.6 Disclosure 2026/09/24 09:00
監査報告
最近一年的财务报告及其审计报告以及最近一期的财务报告
Delete
No.5 Disclosure 2026/09/24 09:00
第三者割当増資
关于云南沃森生物技术股份有限公司申请向特定对象发行股票的审核问询函之回复报告
Delete
No.4 Disclosure 2026/09/24 09:00
第三者割当増資
大信会计师事务所(特殊普通合伙)关于公司申请向特定对象发行股票的审核问询函审核函〔2026〕020079号的专项说明
Delete
No.3 Disclosure 2026/09/24 09:00
第三者割当増資
中信证券股份有限公司关于公司2026年度向特定对象发行股票之发行保荐书
Delete
No.2 Disclosure 2026/09/24 09:00
第三者割当増資
中信证券股份有限公司关于公司2026年度向特定对象发行股票之上市保荐书
Delete
No.1 Disclosure 2026/09/24 09:00
第三者割当増資
北京市竞天公诚律师事务所关于云南沃森生物技术股份有限公司2026年度向特定对象发行股票的补充法律意见书(二)
Delete

Write on the Walvax Biotechnology Co., Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English